Reporting Amount of Listed Drugs and Biological Products Under Section 510(j)(3) of the FD&C Act; Draft Guidance for Industry; Availability

4 organizations filed 6 public comments on Reporting Amount of Listed Drugs and Biological Products Under Section 510(j)(3) of the FD&C Act; Draft Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 1667d ago.

Commenters (4)

• Animal Health Institutetrade assoc.

  2 filings · confidence 97%
• Association for Accessible Medicinestrade assoc.

  2 filings · confidence 97%
• Consumer Healthcare Products Associationtrade assoc.

  1 filing · confidence 97%
• Parenteral Drug Associationtrade assoc.

  1 filing · confidence 97%